Pfizer Inc. (NYSE:PFE) has so far failed in its $120 billion quest to buy its British rival AstraZeneca PLC. At least one analyst says the pressure is on for the pharmaceutical giant to get a big deal done and done quickly. Pfizer Inc. (NYSE:PFE) stock performance was -0.16% in last session and finished the day at $30.34. Traded volume was 14.84million shares in the last session … Continue reading Best Stocks – Pfizer Inc. (NYSE:PFE) , Glu Mobile (NASDAQ:GLUU) , Central Garden & Pet Co (NASDAQ:CENT) , Cray (NASDAQ:CRAY) , Amedica (NASDAQ:AMDA)